Danske Bank’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Other funds holding ACET
Danske Bank's ACET Position: Q3 2026 in Review
Danske Bank held its Adicet Bio (ACET) position steady in Q3 2026 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #1073.
Danske Bank first reported a position in ACET in Q4 2025 and has held it in 4 quarters since. The position peaked at $9 in Q2 2026. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2026.
- Danske Bank held 1 share of Adicet Bio worth $7 as of Q3 2026.
- Danske Bank left its Adicet Bio share count unchanged in Q3 2026.
- Adicet Bio made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1073 holding.
- Danske Bank first reported a position in Adicet Bio in Q4 2025 and has held it in 4 quarters since.
- Danske Bank's Adicet Bio position peaked at $9 in Q2 2026.
- 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.